Skip to content
Ralinepag
Ralinepag is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
6 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pulmonary arterial hypertensionD000081029235
HypertensionD006973EFO_0000537I1033
Pulmonary hypertensionD006976EFO_0001361I27.2033
Cardiovascular diseasesD002318EFO_0000319I9833
Respiratory tract diseasesD01214033
Connective tissue diseasesD003240EFO_1001986M3533
Vascular diseasesD014652EFO_0004264I7733
Lung diseasesD008171EFO_0003818J98.433
Familial primary pulmonary hypertensionD065627I27.033
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pharmacogenomic testingD00007118511
Healthy volunteers/patients11
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameRALINEPAG
INNralinepag
Description
Ralinepag is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification
Small molecule
Drug classnon-prostanoid prostaglandin receptor agonists
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1
Identifiers
PDB
CAS-ID1187856-49-0
RxCUI
ChEMBL IDCHEMBL3301604
ChEBI ID
PubChem CID
DrugBank
UNII IDCQY12ZJN6E (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 23 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3 adverse events reported
View more details